Australia markets closed

Changjiang Pharmaceutical Group Co., Ltd. (300391.SZ)

Shenzhen - Shenzhen Delayed price. Currency in CNY
Add to watchlist
3.5000+0.1100 (+3.24%)
At close: 03:04PM CST

Changjiang Pharmaceutical Group Co., Ltd.

Fudi Center
Room 1308 Shengcheng Street
Shouguang 262700
China

https://www.chinakangyue.com

Sector(s)Healthcare
IndustryDrug Manufacturers - Specialty & Generic
Full-time employees596

Key executives

NameTitlePayExercisedYear born
Mr. Ming LuoGM & DirectorN/AN/A1977
Mr. Luhong NingDirector, Secretary of the Board of Directors & Deputy GMN/AN/A1971
Mr. Yuexiao YangDeputy General ManagerN/AN/A1980
Amounts are as of , and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CNY.

Description

Changjiang Pharmaceutical Group Co., Ltd., together with its subsidiaries, engages in the production and distribution of pharmaceuticals and photovoltaic equipment in China and internationally. It offers photovoltaic equipment, such as laminating machines and stitch welding machines; tablets and hollow capsules; and Chinese herbal beverages, as well as engages in pharmaceutical distribution business. The company was formerly known as Kangyue Technology Co., Ltd. and changed its name to Changjiang Pharmaceutical Group Co., Ltd. in March 2023. Changjiang Pharmaceutical Group Co., Ltd. was founded in 1963 and is based in Shouguang, China.

Corporate governance

Changjiang Pharmaceutical Group Co., Ltd.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.